Ladenburg Thalmann Financial Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$987K Buy
23,445
+427
+2% +$18.6K 0.01% 1295
2019
Q3
$829K Buy
23,018
+10,460
+83% +$317K 0.01% 1370
2019
Q2
$337K Sell
12,558
-1,249
-9% -$31.9K ﹤0.01% 2052
2019
Q1
$372K Buy
13,807
+708
+5% +$16.5K ﹤0.01% 1912
2018
Q4
$225K Sell
13,099
-281
-2% -$5.46K ﹤0.01% 2155
2018
Q3
$279K Buy
13,380
+6,658
+99% +$105K ﹤0.01% 2042
2018
Q2
$145K Hold
6,722
﹤0.01% 2475
2018
Q1
$145K Buy
6,722
+573
+9% +$15.9K ﹤0.01% 2475
2017
Q4
$186K Sell
6,149
-360
-6% -$11.5K ﹤0.01% 2256
2017
Q3
$247K Buy
6,509
+2,358
+57% +$76.7K ﹤0.01% 1944
2017
Q2
$116K Buy
4,151
+1,590
+62% +$47.4K ﹤0.01% 2421
2017
Q1
$88K Buy
2,561
+561
+28% +$19.8K ﹤0.01% 2482
2016
Q4
$59K Buy
2,000
+123
+7% +$3.25K ﹤0.01% 2715
2016
Q3
$59K Buy
1,877
+739
+65% +$25.1K ﹤0.01% 2662
2016
Q2
$36K Buy
1,138
+149
+15% +$4.99K ﹤0.01% 2927
2016
Q1
$27K Sell
989
-142
-13% -$3.1K ﹤0.01% 3034
2015
Q4
$40K Sell
1,131
-31
-3% -$1.09K ﹤0.01% 2725
2015
Q3
$38K Buy
1,162
+187
+19% +$7.78K ﹤0.01% 2653
2015
Q2
$41K Buy
975
+595
+157% +$23K ﹤0.01% 2719
2015
Q1
$12K Buy
380
+265
+230% +$9.11K ﹤0.01% 3491
2014
Q4
$4K Hold
115
﹤0.01% 3794
2014
Q3
$3K Hold
115
﹤0.01% 3550
2014
Q2
$3K Buy
115
+90
+360% +$1.88K ﹤0.01% 3511
2014
Q1
$1K Sell
25
-620
-96% -$15.7K ﹤0.01% 3600
2013
Q4
$16K Buy
645
+620
+2,480% +$14.6K ﹤0.01% 2654
2013
Q3
$1K Buy
+25
New +$523 ﹤0.01% 3530

Other funds holding ACAD